Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 15601486)

Published in Int J STD AIDS on December 01, 2004

Authors

Mari M Kitahata1, Shelby D Reed, Peter W Dillingham, Stephen E Van Rompaey, Alicia A Young, Robert D Harrington, King K Holmes

Author Affiliations

1: Department of Medicine, University of Washington, Seattle, Washington 98104, USA. kitahata@u.washington.edu

Articles citing this

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav (2006) 8.11

Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med (2005) 2.83

Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis (2011) 1.77

A proposal for quality standards for measuring medication adherence in research. AIDS Behav (2013) 1.51

Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals. Bull World Health Organ (2008) 1.49

Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States. PLoS One (2012) 1.44

Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire. J Acquir Immune Defic Syndr (2011) 1.34

Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS (2008) 1.33

Quality of HIV care provided by non-physician clinicians and physicians in Mozambique: a retrospective cohort study. AIDS (2010) 1.28

Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc (2009) 1.25

Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management of HIV? Behav Ther (2007) 1.25

Medication Adherence Measures: An Overview. Biomed Res Int (2015) 1.16

Virologic, clinical and immunologic responses following failure of first-line antiretroviral therapy in Haiti. J Int AIDS Soc (2012) 1.11

Medication adherence mediates the relationship between adherence self-efficacy and biological assessments of HIV health among those with alcohol use disorders. AIDS Behav (2007) 1.08

Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV. BMJ Open (2013) 1.07

Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents. AIDS Care (2012) 1.02

Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence. J Acquir Immune Defic Syndr (2012) 0.96

Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons. J Acquir Immune Defic Syndr (2013) 0.95

Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these? Global Health (2010) 0.93

Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. AIDS Behav (2013) 0.92

Optimizing the effects of stress management interventions in HIV. Health Psychol (2008) 0.90

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis. Medicine (Baltimore) (2016) 0.88

The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention. AIDS Behav (2014) 0.81

Influence of provider experience on antiretroviral adherence and viral suppression. HIV AIDS (Auckl) (2012) 0.75

Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice. Medicine (Baltimore) (2017) 0.75

Impact of a pharmaceutical care program on clinical evolution and antiretroviral treatment adherence: a 5-year study. Patient Prefer Adherence (2013) 0.75

The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients. Contemp Clin Trials (2016) 0.75

Articles by these authors

Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep (2009) 11.30

Global health in medical education: a call for more training and opportunities. Acad Med (2007) 8.85

Global health training and international clinical rotations during residency: current status, needs, and opportunities. Acad Med (2009) 6.31

Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med (2006) 5.69

Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health (2009) 4.29

Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med (2005) 3.96

Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72

Update on syphilis: resurgence of an old problem. JAMA (2003) 3.31

Association between Mycoplasma genitalium and acute endometritis. Lancet (2002) 3.27

Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis (2004) 3.18

Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. Int J Epidemiol (2008) 3.14

Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med (2009) 3.13

Partner reduction is crucial for balanced "ABC" approach to HIV prevention. BMJ (2004) 3.12

Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS (2006) 3.11

HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS (2002) 3.03

Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis (2003) 2.88

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep (2002) 2.86

A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis (2004) 2.62

"It takes a village": understanding concurrent sexual partnerships in Seattle, Washington. Sex Transm Dis (2002) 2.56

Sex partner concurrency: measurement, prevalence, and correlates among urban 18-39-year-olds. Sex Transm Dis (2002) 2.46

Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sex Transm Dis (2006) 2.21

Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis (2008) 2.21

Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation. Int J STD AIDS (2005) 2.19

Do people really know their sex partners? Concurrency, knowledge of partner behavior, and sexually transmitted infections within partnerships. Sex Transm Dis (2004) 2.19

Sexual identity and risk of HIV/STI among men who have sex with men in Nairobi. Sex Transm Dis (2008) 2.11

Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep (2004) 2.05

Discord, discordance, and concurrency: comparing individual and partnership-level analyses of new partnerships of young adults at risk of sexually transmitted infections. Sex Transm Dis (2005) 2.05

Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey. Lancet Infect Dis (2012) 2.03

Text messaging to improve attendance at post-operative clinic visits after adult male circumcision for HIV prevention: a randomized controlled trial. PLoS One (2012) 1.85

Handheld computers for self-administered sensitive data collection: a comparative study in Peru. BMC Med Inform Decis Mak (2008) 1.82

Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin Infect Dis (2011) 1.82

Comprehensive health care for people infected with HIV in developing countries. BMJ (2002) 1.81

Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet (2012) 1.80

Epidemic Lymphogranuloma venereum during epidemics of crack cocaine use and HIV infection in the Bahamas. Sex Transm Dis (2002) 1.79

Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health (2007) 1.78

What do international pharmacoeconomic guidelines say about economic data transferability? Value Health (2010) 1.74

Measuring sex partner concurrency: it's what's missing that counts. Sex Transm Dis (2007) 1.73

Determinants and prevalence of HIV infection in pregnant Peruvian women. AIDS (2003) 1.72

Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis (2006) 1.72

Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis (2003) 1.70

Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann Intern Med (2007) 1.69

Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J Infect Dis (2005) 1.69

Anal intercourse among young heterosexuals in three sexually transmitted disease clinics in the United States. Sex Transm Dis (2009) 1.68

Design and implementation of Cell-PREVEN: a real-time surveillance system for adverse events using cell phones in Peru. AMIA Annu Symp Proc (2005) 1.65

Importance of sex partner HIV status in HIV risk assessment among men who have sex with men. J Acquir Immune Defic Syndr (2004) 1.64

Sentinel surveillance of sexually transmitted infections/HIV and risk behaviors in vulnerable populations in 5 Central American countries. J Acquir Immune Defic Syndr (2007) 1.63

Training pharmacy workers in recognition, management, and prevention of STDs: district-randomized controlled trial. Bull World Health Organ (2004) 1.63

Measures of sexual partnerships: lengths, gaps, overlaps, and sexually transmitted infection. Sex Transm Dis (2006) 1.61

Independent association of hygiene, socioeconomic status, and circumcision with reduced risk of HIV infection among Kenyan men. J Acquir Immune Defic Syndr (2006) 1.60

Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir. AIDS (2007) 1.60

Correlates of national HIV seroprevalence: an ecologic analysis of 122 developing countries. J Acquir Immune Defic Syndr (2004) 1.59

Transmission of STIs/HIV at the partnership level: beyond individual-level analyses. J Urban Health (2003) 1.58

From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis (2008) 1.58

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med (2002) 1.57

Electronic human immunodeficiency virus (HIV) clinical reminder system improves adherence to practice guidelines among the University of Washington HIV Study Cohort. Clin Infect Dis (2003) 1.56

Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS. J Gen Intern Med (2003) 1.56

Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients. Ann Surg (2015) 1.55

Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients. Curr HIV Res (2007) 1.55

Clandestine induced abortion: prevalence, incidence and risk factors among women in a Latin American country. CMAJ (2009) 1.55

A multinational review of recent trends and reports in dementia caregiver burden. Alzheimer Dis Assoc Disord (2004) 1.55

Reproductive tract infections in rural women from the highlands, jungle, and coastal regions of Peru. Bull World Health Organ (2004) 1.54

Spatial bridges for the importation of gonorrhea and chlamydial infection. Sex Transm Dis (2003) 1.54

Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveill Summ (2016) 1.54

Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis (2005) 1.46

"It's time for your life": How should we remind patients to take medicines using short text messages? AMIA Annu Symp Proc (2009) 1.42

Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med (2008) 1.41

Partner notification for HIV and STD in the United States: low coverage for gonorrhea, chlamydial infection, and HIV. Sex Transm Dis (2003) 1.38

Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol (2005) 1.38

Sexual networks of pregnant women with and without HIV infection. AIDS (2003) 1.34

Moving upstream: ecosocial and psychosocial correlates of sexually transmitted infections among young adults in the United States. Am J Public Health (2008) 1.33

Advances in multilevel approaches to understanding the epidemiology and prevention of sexually transmitted infections and HIV: an overview. J Infect Dis (2005) 1.33

Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS (2008) 1.33

Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2014) 1.30

Comparative geographic concentrations of 4 sexually transmitted infections. Am J Public Health (2005) 1.29

Ongoing risk behavior among persons with HIV in medical care. AIDS Behav (2007) 1.29

Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerg Infect Dis (2003) 1.29

Bacterial vaginosis: risk factors among Kenyan women and their male partners. Sex Transm Dis (2006) 1.28

Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010. Ann Intern Med (2013) 1.27

Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg (2014) 1.26

A comparison of sexual behavior patterns among men who have sex with men and heterosexual men and women. J Acquir Immune Defic Syndr (2012) 1.26

Can we close the income and wealth gap between specialists and primary care physicians? Health Aff (Millwood) (2010) 1.25

Azithromycin versus penicillin G benzathine for early syphilis. N Engl J Med (2005) 1.23

High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr (2013) 1.23

Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med (2005) 1.23

Sexually transmitted diseases in the USA: temporal trends. Sex Transm Infect (2007) 1.21

Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. Am J Obstet Gynecol (2004) 1.20

Temporal trends in sexual behaviors and sexually transmitted disease history among 18- to 39-year-old Seattle, Washington, residents: results of random digit-dial surveys. Sex Transm Dis (2005) 1.20

Who is getting Pap smears in urban Peru? Int J Epidemiol (2008) 1.19

Rapid Syphilis Tests as Catalysts for Health Systems Strengthening: A Case Study from Peru. PLoS One (2013) 1.16

The cost-effectiveness of syndromic management in pharmacies in Lima, Peru. Sex Transm Dis (2003) 1.15

Associations between intravaginal practices and bacterial vaginosis in Kenyan female sex workers without symptoms of vaginal infections. Sex Transm Dis (2007) 1.12

Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation. Blood (2008) 1.10

Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. Clin Infect Dis (2011) 1.10

Influence of study population on the identification of risk factors for sexually transmitted diseases using a case-control design: the example of gonorrhea. Am J Epidemiol (2004) 1.10

Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs. Pediatr Infect Dis J (2009) 1.09

Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C. Antivir Ther (2012) 1.09